Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 27, 1058-1065, June 1, 1967]
© 1967 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vincent, P. C.
Right arrow Articles by Nicholls, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vincent, P. C.
Right arrow Articles by Nicholls, A.

Comparison of the Growth of the Ehrlich Ascites Tumor in Male and Female Mice

Paul C. Vincent1 and Annette Nicholls

The The Wellcome Laboratories for Experimental Medicine and Surgery, Institute of Medical Research, the Royal North Shore Hospital of Sydney, Sydney, Australia

In a long-term study of 2 sublines of the Ehrlich ascites tumor, one maintained in male mice and the other in females, significantly less growth occurred with the tumor from male donors when tested in mice of either sex. In addition, significantly less growth occurred in male than in female mice inoculated with tumor from either subline; the 2 effects, due to the sex of the donor and to the sex of the recipient, could be clearly distinguished. Despite the differences in tumor growth, however, the only significant prolongation of survival in male mice was found in those inoculated with 105 cells and not in those inoculated with 106 or 107 cells. Subcutaneous tumor inoculation 1 week prior to intraperitoneal injection resulted in prolonged survival in 55% of treated mice, but this effect was not related to the subline of the tumor used. A change in the modal chromosome number, from 44 to 45 per cell, occurred in both sublines; this was more marked in the subline maintained in males than it was in the subline in females. In addition, the number of metacentric marker chromosomes increased from 1 to 2 per cell in almost all cells of each subline.

The results suggest that differences between the growth of tumor maintained in male or female mice were due to the selection, in male animals, of cells with a decreased growth potential. Such a selection may have been related to the relatively poor tumor growth found in male mice inoculated from either subline. The relevance of these results to experimental tumor studies is discussed.

1 British Tobacco Co. Fellow in Cancer Research. Present address: Medical Department, Brookhaven National Laboratory, Upton, Long Island, New York 11973.

Received 6/ 8/66. Accepted 1/11/67.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1967 by the American Association for Cancer Research.